Royal Australian College of General Practitioners (RACGP)·3 min read·medium
New Sublocade transfer guidelines published
✦AI Summary
NSW Health has released consensus advice for GPs to help patients transition from the opioid dependency medication Sublocade. The drug is being withdrawn from the Australian market by its manufacturer, Indivior, by the end of the year.
Why it matters
This change affects thousands of patients reliant on long-acting opioid treatment, requiring urgent clinical coordination to prevent treatment disruption.
Consensus advice has been issued as the medication, which is used to treat opioid dependence, will be removed from the PBS in December.
healthbusiness
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in